memantine, an investigational drug for Alzheimer's

July 2003

There's lots of interest in memantine, an investigational drug for Alzheimer's.

New evidence suggests it's beneficial for patients with moderate to SEVERE Alzheimer's.

Aricept, Exelon, and Reminyl are for mild to moderate cases.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote